\nHomocysteine concentrations can increase primarily as a result of specific genetic defects of the enzymes responsible for its metabolism<\/strong>, as well as deficiencies of cofactors involved in this pathway, such as vitamins B6, B12, and folic acid.
\nSuch deficiencies are secondary to reduced intake or absorption and the use of specific medications. https:\/\/doi.org\/10.1177\/1179573520962230<\/a><\/p>\n
\n\t <\/h2>\n Homocysteine and cardiovascular risk<\/h2>\n
Numerous epidemiological studies have established a close link between elevated homocysteine levels and cardiovascular disease. In 1997, a very important study was carried out in Europe to establish the magnitude of the risk of CVD associated with an elevated level of plasma homocysteine and to examine the effects of interaction between these and conventional risk factors. Homocysteine can promote endothelial dysfunction, oxidative stress, inflammation, and thrombosis, all of which contribute to the development and progression of atherosclerosis. Another study conducted in 2020 attempted to determine the relationship between elevated homocysteine levels and peripheral artery disease. The result obtained ratified the previously existing studies<\/strong> and highlighted the joint effect of high homocysteine concentration and traditional cardiovascular risk factors such as smoking, diabetes and aging on the incidence of peripheral arterial disease. While clinical trials have provided valuable insights into the relationship between homocysteine and cardiovascular risk, it is important to note that they primarily serve as examples in our research during the preparation of this article. However, the impact of homocysteine-lowering therapy on cardiovascular outcomes has been inconsistent<\/strong>, so it is important to consider the potential benefits of managing homocysteine levels. Although homocysteine is not currently recommended as a stand-alone marker for cardiovascular risk assessment, it may be useful in combination with other established risk factors. Homocysteine-lowering supplements<\/strong> often contain nutrients such as folic acid, vitamin B6, and vitamin B12, which are involved in your metabolism. One of them is the maintenance of the proper functioning of their metabolism and metabolic processes that require methyl group donation<\/strong>. It has been strongly hypothesized that lowering homocysteine levels has cardiovascular benefits. Homocysteine-lowering supplements can synergistically complement other interventional strategies for reducing cardiovascular risk. In some individuals, genetic variations can be observed that predispose them to higher levels of homocysteine. It is important to note that before starting any new supplement regimen, it is recommended to consult with a healthcare professional so that they can assess your individual health status, the suitability of the supplements, and provide personalized recommendations based on your specific needs.<\/p>\n<\/p>\n
\nHowever, the underlying mechanisms and causal relationship between homocysteine and CVD are still being studied.
\nThe research has explored the association between homocysteine and various aspects of cardiovascular risk<\/strong>, shedding light on its potential as a predictive marker.
\nCurrent predictive parameters of specific cardiovascular risk indicate that a high plasma level of homocysteine significantly increases the incidence of vascular damage in both small and large vessels. <\/p>\n
\nThe result was that an elevated plasma level of total homocysteine confers an independent risk of vascular disease similar to that of smoking or hyperlipidemia, and this risk is powerfully increased when associated with hypertension<\/strong>.
\nDOI: 10.1001\/jama.1997.03540460039030<\/a> <\/p>\n<\/p>\n![\"\"](\"http:\/\/salengei.com\/wp-content\/uploads\/homocisteina_analitica.jpg\")
<\/p>\n<\/p>\n
\nIn addition, elevated homocysteine levels can affect vascular endothelial cell function, disrupt nitric oxide production, and lead to arterial stiffness and hypertension.<\/strong> <\/p>\n
\nDOI: 10.2147\/DMSO. S267122<\/a> <\/p>\n<\/p>\n Perspectives<\/h2>\n
\nHowever, these important findings contribute to a better understanding of the role of homocysteine in CVD. <\/p>\n
\n Lifestyle modifications, including a healthy diet rich in B vitamins (folate, vitamin B6, and vitamin B12<\/strong>), can help maintain optimal homocysteine levels.
\nIn addition, individuals with certain genetic variations may have a greater predisposition to hyperhomocysteinemia and may benefit from personalized interventions.
\nDOI: 10.1055\/s-2000-8101<\/a> <\/p>\n
\nAssessing homocysteine levels along with traditional risk factors such as age, smoking, blood pressure, lipid profile, and family history can provide a more comprehensive assessment of an individual’s cardiovascular risk. <\/p>\n<\/p>\n Possible interventions<\/h2>\n
\nThese supplements are commonly recommended for people with elevated homocysteine levels or those at increased risk of cardiovascular disease.
\nWhile the specific benefits of taking two capsules of Active Homocystrol+TMG<\/strong><\/a> daily cannot be disputed, it is good to inquire a little more about the benefits. <\/p>\n
\nRemethylation of homocysteine to methionine requires folic acid in its active form 5-methyl TFH.
\nTo obtain 5-methyl TFH, the MTHFR gene is needed as a catalyst and riboflavin as a cofactor.
\nOnce in their active form, folate can cede its methyl group to homocysteine, allowing the remethylation process.
\nThis process is catalyzed by the MS gene and requires methylcobalamin as a cofactor.
\nAn alternative route for methionine remethylation to occur is from betaine degradation by the BHTM gene.
\nBetaine can be obtained from the diet or from choline oxidation. <\/p>\n
\nWhile the direct impact on cardiovascular outcomes continues to be studied, it is suggested that lowering homocysteine levels may help improve endothelial function, reduce inflammation, and improve vascular health<\/strong>.
\nThese effects could potentially contribute to a decreased risk of developing cardiovascular disease, such as coronary artery disease and stroke. <\/p>\n
\nThey can be used in conjunction with lifestyle modifications, including a healthy diet, regular exercise, and smoking cessation for good.<\/strong> The combination of these interventions may provide a more comprehensive approach to managing cardiovascular risk factors. <\/p>\n
\nIn such cases, reducing supplements may be particularly beneficial.
\nThese supplements can help compensate for impaired enzyme activity<\/strong> and help maintain optimal homocysteine levels, thereby reducing the associated cardiovascular risk. <\/p>\n
![\"\"](\"http:\/\/salengei.com\/wp-content\/uploads\/230620-_banner_homocystrol_desktop.jpg\")
<\/a><\/p>\n<\/p>\n